 |
| The eight-story, 200,000-SF GENESIS-San Diego building in downtown San Diego, CA is 50 percent leased |
SAN DIEGO, CA – Confirming that Downtown San Diego is a growing life science cluster, Phase 3 Real Estate Partners, Inc. has proudly announced its newest lease with AnaBios within the highly coveted GENESIS-San Diego.
This cutting-edge, eight-story, 200,000-square-foot Class A life science
building, established itself as a premiere facility for some of the most
forward-thinking life science companies in San Diego.
Andre Ghetti
 |
| Chad Urie |
AnaBios is joined by Novoron Bioscience, Excellos and Native Microbials in downtown's newest wet lab building.
AnaBios will use the space to continue
offering their clients cutting-edge drug discovery and research translational
services based on of high-quality human tissue and cells, including heart,
lung, and dorsal root ganglia.
"We believe that being located in
downtown San Diego near other life science firms, the Convention Center and the
airport will provide a key catalyst for our growth," said Andre Ghetti,
Founder and Chief Executive Officer at AnaBios.
"The unmatched resources, inspiring environment, and unwavering
commitment to innovation offered by Phase 3 Real Estate Partners align
perfectly with our vision for the future.”
Grant Schoneman
JLL’s Chad Urie, Grant Schoneman and
Taylor DeBerry represented the landlord, Phase 3 Real Estate Partners, in
the lease. AnaBios was represented by Jon Engle and John Hundley
of Newmark. GENESIS San Diego can accommodate users ranging from 7,500 square
feet and larger.
"Downtown San Diego is emerging as
a vibrant hub for innovative life science companies, and AnaBios' decision to
join the impressive lineup at GENESIS reflects the area’s appeal,” said Jon
Engle, Newmark Managing Director.
“The city's collaborative
environment, coupled with the cutting-edge facilities provided by Phase 3 Real
Estate Partners, is fostering an ecosystem where companies like AnaBios can
thrive and advance groundbreaking discoveries and scientific research."
Taylor DeBerry
Phase 3 Real Estate Partners Inc., in
partnership with Barings and Bain Capital Real Estate, completed the
Genesis-San Diego life science conversion in mid-2022, delivering robust
infrastructure, premier finishes and thoughtful designs that were curated
allowing today’s top biotech companies space to grow, and succeed in their
endeavours.
Learn more at www.GENESIS-SanDiego.com.
About Phase 3 Real Estate Partners
Jon Engle
Phase 3 Real Estate Partners, Inc., ("Phase 3")
develops premier ready to occupy research and development facilities in the
major innovation clusters of the United States.
Phase 3's focus
on delivering the highest quality space with accelerated speed to occupancy
within these key geographies allows companies to immediately pursue their
scientific goals.
The Phase 3 team
delivers a clean, modern design aesthetic, the right combination of amenities
to create community and appropriate infrastructure to meet the needs of the
companies who call our facilities home.
 |
| John Hundley |
The firm's expertise in development, construction and management of life science facilities results in a strong partnership between our tenants and our team.
Phase 3's current portfolio consists of
nearly 4.5 million square feet and is growing in San Diego, San Francisco and
Boston.
About Barings
Barings is a $362+ billion* global
investment manager sourcing differentiated opportunities and building long-term
portfolios across public and private fixed income, real estate, and specialist
equity markets.
With
investment professionals based in North America, Europe and Asia Pacific, the
firm, a subsidiary of MassMutual, aims to serve its clients, communities and
employees, and is committed to sustainable practices and responsible investment.
Genesis-SD3
*As of March 31, 2023
CONTACT:
David Ebeling
Ebeling Communications
949.861.8351
949.278.7851 (Cell)
Member of the National Association
of Real Estate Editors (NAREE)
“PR
Strategist for the Commercial Real Estate Industry: I do what I love and
love what I do.”
No comments:
Post a Comment